The global BoneMorphogenetic Protein Market is set to witness a higher CAGR during the forecast period. Molecular cloning of bone morphogenetic proteins validate their family of differentiation factors and each capable of stimulating the development of new bone tissue once implanted. Morphogenetic based products are a revolution for several therapies in orthopaedic practices. Technically, bone matrix comprises a diversity of protein components entailing an array of growth and differentiation factors. Developments in the biochemical techniques and inception of biotechnology certainly allows purification followed by molecular cloning
Driving
factors for bone morphogenetic proteins market include rise in number of
patients with spinal injuries along with an increase in surgical rate. Rise in
spinal fusion, small bone surgeries and trauma are likely to propel the market
growth in the forecast period. Low back pain is one of the main reasons
occurring due to lifestyle disorders resulting into severe back conditions.
Subsequently, the rise in orthopaedic surgeries growing by number is likely to
gain a significant attention in the forecast period. By Type, the market is
segmented as rhBMP-2 and rhBMP-7. Application segment for bone morphogenetic
protein market includes trauma, spinal fusion, reconstructive surgery and
oral-maxillofacial.
Request Sample Copy of This Market Research @
https://www.millioninsights.com/industry-reports/bone-morphogenetic-proteins-market/request-sample
Geographical
segmentation for bone morphogenetic protein (BMP) market includes North
America, South America, Europe, Asia-Pacific, Middle East and Africa.
Asia-Pacific regions are likely to gain a significant market growth due to rise
in orthopaedic conditions and change in lifestyle. Favorable reimbursement is a
major reason for market development.
North
American and European regions are likely to attain higher position due to rise in
minimally invasive surgeries, higher recovery time and rise in geriatric
population. In addition, rise in awareness about alternatives for bone grafting
is contributing to the market growth. The key players in the bone morphogenetic
protein industry include Medtronic, R&D Systems, Sigma Aldrich Corp,
ProSpec, DePuySynthes, Ember Therapeutics Inc and Cellumed Co Ltd.
Browse Full Research Report @
https://www.millioninsights.com/industry-reports/bone-morphogenetic-proteins-market
Market Segment:
Type
Outlook (Market Revenue in USD Million, 2013 - 2024)
• rhBMP-2
• rhBMP-7
Application
Outlook (Market Revenue in USD Million, 2013 - 2024)
• Spinal fusion
• Trauma
• Reconstruction
• Oral Maxillofacial
Regional
Outlook (Market Revenue in USD Million, 2013 - 2024)
• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• Japan
• China
• India
• Latin America
• Brazil
• Mexico
• MEA
• South Africa
Read more insights on @
https://latestmarkettrends.news.blog
Get in touch
At Million Insights, we work with the aim to reach the highest levels
of customer satisfaction. Our representatives strive to understand diverse
client requirements and cater to the same with the most innovative and
functional solutions.
Contact Person:
Ryan Manuel
Research Support Specialist, USA
Email: ryan@millioninsights.com
Comments
Post a Comment